Stephens Investment Management Group LLC lessened its stake in shares of Ryan Specialty Holdings, Inc. (NYSE:RYAN – Free Report) by 0.6% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 1,607,595 shares of the company’s stock after selling 9,800 shares during the period. Ryan Specialty makes up about 1.4% of Stephens Investment Management Group LLC’s portfolio, making the stock its 9th biggest position. Stephens Investment Management Group LLC owned approximately 0.61% of Ryan Specialty worth $103,143,000 as of its most recent filing with the Securities and Exchange Commission.
A number of other hedge funds have also bought and sold shares of the stock. AQR Capital Management LLC purchased a new position in shares of Ryan Specialty in the second quarter worth about $261,000. Sanctuary Advisors LLC acquired a new position in Ryan Specialty during the second quarter valued at $802,000. GAMMA Investing LLC boosted its holdings in Ryan Specialty by 106.4% in the third quarter. GAMMA Investing LLC now owns 1,249 shares of the company’s stock valued at $83,000 after purchasing an additional 644 shares during the last quarter. UMB Bank n.a. grew its position in Ryan Specialty by 5.2% during the 3rd quarter. UMB Bank n.a. now owns 5,224 shares of the company’s stock worth $347,000 after purchasing an additional 256 shares during the period. Finally, Exchange Traded Concepts LLC purchased a new position in shares of Ryan Specialty during the 3rd quarter valued at about $761,000. Institutional investors and hedge funds own 84.82% of the company’s stock.
Analyst Ratings Changes
RYAN has been the subject of several recent research reports. Barclays lifted their price target on Ryan Specialty from $76.00 to $88.00 and gave the company an “overweight” rating in a research report on Thursday, November 21st. Wells Fargo & Company decreased their target price on shares of Ryan Specialty from $68.00 to $64.00 and set an “equal weight” rating for the company in a research note on Tuesday, January 14th. Keefe, Bruyette & Woods dropped their price target on shares of Ryan Specialty from $79.00 to $77.00 and set an “outperform” rating on the stock in a research report on Friday, January 10th. Finally, Morgan Stanley initiated coverage on shares of Ryan Specialty in a research report on Thursday, December 5th. They issued an “overweight” rating and a $90.00 price objective for the company. One analyst has rated the stock with a sell rating, five have issued a hold rating and six have issued a buy rating to the company’s stock. Based on data from MarketBeat, the stock has a consensus rating of “Hold” and a consensus target price of $74.40.
Ryan Specialty Trading Down 0.4 %
Shares of Ryan Specialty stock opened at $68.24 on Friday. Ryan Specialty Holdings, Inc. has a twelve month low of $42.68 and a twelve month high of $75.97. The firm’s 50-day moving average price is $66.12 and its 200 day moving average price is $66.87. The company has a current ratio of 1.01, a quick ratio of 1.01 and a debt-to-equity ratio of 2.40. The firm has a market capitalization of $17.87 billion, a PE ratio of 88.63, a P/E/G ratio of 1.19 and a beta of 0.72.
Insider Activity
In other Ryan Specialty news, Director Nicholas Dominic Cortezi sold 10,485 shares of the stock in a transaction dated Thursday, January 23rd. The shares were sold at an average price of $65.12, for a total value of $682,783.20. Following the completion of the sale, the director now owns 11,109 shares in the company, valued at approximately $723,418.08. This represents a 48.56 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director David P. Bolger sold 7,055 shares of the business’s stock in a transaction that occurred on Thursday, November 21st. The stock was sold at an average price of $70.88, for a total value of $500,058.40. Following the transaction, the director now owns 78,149 shares in the company, valued at approximately $5,539,201.12. This represents a 8.28 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 323,506 shares of company stock worth $21,407,851 over the last quarter. 11.10% of the stock is currently owned by corporate insiders.
About Ryan Specialty
Ryan Specialty Holdings, Inc operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers in the United States, Canada, the United Kingdom, Europe, and Singapore. It offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter.
Further Reading
- Five stocks we like better than Ryan Specialty
- How to Know Which Cryptocurrency to Buy: A Guide for Investors
- Lam Research: Is a NAND Upgrade Cycle the Next Growth Catalyst?
- What Are Trending Stocks? Trending Stocks Explained
- Chipotle’s Slip: A Short-Term Dip or Long-Term Opportunity?
- How to Most Effectively Use the MarketBeat Earnings Screener
- Why New Tariffs Could Boost These 3 Basic Materials Stocks
Want to see what other hedge funds are holding RYAN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Ryan Specialty Holdings, Inc. (NYSE:RYAN – Free Report).
Receive News & Ratings for Ryan Specialty Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ryan Specialty and related companies with MarketBeat.com's FREE daily email newsletter.